Ledger.Open graph →
SEC Form D · filed February 24, 2021

Enveric Biosciences, Inc

Offering
$8.4M
Sold
—
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NAPLES, FL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Marcus Schabacker · Naples, FLDirectorAvani Kanubaddi · Naples, FLExec · DirectorGeorge Kegler · Naples, FLDirectorDavid Johnson · Naples, FLExec · DirectorSol Mayer · Naples, FLDirectorJohn Van Buiten · Naples, FLExecGenevieve Gilbreath · Austin, TXExec · DirectorTodd A. Wyatt · Royal Oak, MIExec · DirectorScott A. Fine · Westport, CTDirectorBrian Blagg · Indianapolis, INDirectorMark Lee · New York, NYDirectorRobert J. Moser · Saratoga Springs, NYExecRalph N. Strayhorn, Iii · Charlotte, NCExec · DirectorRonan Guilfoyle · George Town, Grand Cayman, Cayman IslandsExec · DirectorMaureen Z. Offer · Menlo Park, CADirectorThomas J. Bartos · Independence, OHDirectorGary A. Zdolshek · Independance, OHExecGarrett E. Zdolshek · Independence, OHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗